Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes

Daniel M. Ihnat, Joseph L Mills

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Endovascular therapy has increasingly become the initial clinical option for the treatment of lower-extremity peripheral arterial occlusive disease not only for patients with claudication but also for those with critical limb ischemia. Despite this major clinical practice paradigm shift, the outcomes of endovascular therapy for peripheral arterial disease are difficult to evaluate and compare with established surgical benchmarks because of the lack of prospective randomized trials, incomplete characterization of indications for intervention, mixing of arterial segments and extent of disease treated, the multiplicity of endovascular therapy techniques used, the exclusion of early treatment failures, crossover to open bypass during follow-up, and the frequent lack of intermediate and long-term patency and limb salvage rates in life-table format. These data limitations are especially problematic when one tries to assess the outcomes of endovascular therapy in patients with diabetes. The purpose of the present article is to succinctly review and objectively analyze available data regarding the results of endovascular therapy in patients with diabetes.

Original languageEnglish (US)
Pages (from-to)424-428
Number of pages5
JournalJournal of the American Podiatric Medical Association
Volume100
Issue number5
StatePublished - Sep 2010

Fingerprint

Arterial Occlusive Diseases
Peripheral Arterial Disease
Therapeutics
Benchmarking
Endovascular Procedures
Limb Salvage
Life Tables
Treatment Failure
Lower Extremity
Ischemia
Extremities

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Podiatry

Cite this

@article{0b14020b5c294b97bb31a02fbe5b2ee4,
title = "Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes",
abstract = "Endovascular therapy has increasingly become the initial clinical option for the treatment of lower-extremity peripheral arterial occlusive disease not only for patients with claudication but also for those with critical limb ischemia. Despite this major clinical practice paradigm shift, the outcomes of endovascular therapy for peripheral arterial disease are difficult to evaluate and compare with established surgical benchmarks because of the lack of prospective randomized trials, incomplete characterization of indications for intervention, mixing of arterial segments and extent of disease treated, the multiplicity of endovascular therapy techniques used, the exclusion of early treatment failures, crossover to open bypass during follow-up, and the frequent lack of intermediate and long-term patency and limb salvage rates in life-table format. These data limitations are especially problematic when one tries to assess the outcomes of endovascular therapy in patients with diabetes. The purpose of the present article is to succinctly review and objectively analyze available data regarding the results of endovascular therapy in patients with diabetes.",
author = "Ihnat, {Daniel M.} and Mills, {Joseph L}",
year = "2010",
month = "9",
language = "English (US)",
volume = "100",
pages = "424--428",
journal = "Journal of the American Podiatric Medical Association",
issn = "8750-7315",
publisher = "American Podiatric Medical Association",
number = "5",

}

TY - JOUR

T1 - Current assessment of endovascular therapy for infrainguinal arterial occlusive disease in patients with diabetes

AU - Ihnat, Daniel M.

AU - Mills, Joseph L

PY - 2010/9

Y1 - 2010/9

N2 - Endovascular therapy has increasingly become the initial clinical option for the treatment of lower-extremity peripheral arterial occlusive disease not only for patients with claudication but also for those with critical limb ischemia. Despite this major clinical practice paradigm shift, the outcomes of endovascular therapy for peripheral arterial disease are difficult to evaluate and compare with established surgical benchmarks because of the lack of prospective randomized trials, incomplete characterization of indications for intervention, mixing of arterial segments and extent of disease treated, the multiplicity of endovascular therapy techniques used, the exclusion of early treatment failures, crossover to open bypass during follow-up, and the frequent lack of intermediate and long-term patency and limb salvage rates in life-table format. These data limitations are especially problematic when one tries to assess the outcomes of endovascular therapy in patients with diabetes. The purpose of the present article is to succinctly review and objectively analyze available data regarding the results of endovascular therapy in patients with diabetes.

AB - Endovascular therapy has increasingly become the initial clinical option for the treatment of lower-extremity peripheral arterial occlusive disease not only for patients with claudication but also for those with critical limb ischemia. Despite this major clinical practice paradigm shift, the outcomes of endovascular therapy for peripheral arterial disease are difficult to evaluate and compare with established surgical benchmarks because of the lack of prospective randomized trials, incomplete characterization of indications for intervention, mixing of arterial segments and extent of disease treated, the multiplicity of endovascular therapy techniques used, the exclusion of early treatment failures, crossover to open bypass during follow-up, and the frequent lack of intermediate and long-term patency and limb salvage rates in life-table format. These data limitations are especially problematic when one tries to assess the outcomes of endovascular therapy in patients with diabetes. The purpose of the present article is to succinctly review and objectively analyze available data regarding the results of endovascular therapy in patients with diabetes.

UR - http://www.scopus.com/inward/record.url?scp=78650271452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78650271452&partnerID=8YFLogxK

M3 - Article

C2 - 20847357

AN - SCOPUS:78650271452

VL - 100

SP - 424

EP - 428

JO - Journal of the American Podiatric Medical Association

JF - Journal of the American Podiatric Medical Association

SN - 8750-7315

IS - 5

ER -